Growth of the Cell Therapy Raw Materials Market Trends, Regional Insights and Key Players
The global cell therapy raw materials market is valued at approximately $5.43 billion in 2024 and is expected to grow to $6.75 billion by 2025. By 2034, the market is projected to reach nearly $48.54 billion, reflecting a significant annual growth rate of 24.5% from 2025 to 2034. The increase in demand for cell therapies, particularly in treating conditions like cancer, rare diseases, and genetic disorders, is a key driver of this market’s growth.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5399
Understanding the Cell Therapy Raw Materials Market
Cell therapy raw materials refer to substances used in the manufacturing of cell, tissue-engineered, or gene therapies, which are not part of the final product. These include components such as cell isolation reagents, culture media, cryopreservation solutions, and disposables like plasticware and bioprocessing bags. The choice of raw materials plays a crucial role in ensuring the safety and effectiveness of the final therapy. By selecting the right materials early from trusted suppliers, manufacturers can streamline production, reduce costs, and improve the chances of regulatory approval.
The rapid advancement of cell and gene therapy is evident in the growing number of clinical trials and approved treatments. As the field expands, so does the focus on optimizing the materials and manufacturing processes involved in creating these therapies.
Key Market Developments and Trends
- In December 2024, PHC Corporation of North America will present its LiCellGrow cell expansion device at Advanced Therapies Week. This innovative technology aims to revolutionize cell and gene therapy production by offering real-time insights into cellular metabolic processes.
- In December 2023, FUJIFILM Corporation announced a $200 million investment in two subsidiaries to enhance its contract development and manufacturing services for cell therapies. This move is aimed at supporting the fast-growing market, which is expected to expand from $3.3 billion in 2022 at a 30% annual growth rate.
- In October 2023, Bayer AG invested $250 million to establish a new cell therapy production facility in Berkeley, California. This facility will be critical in producing the necessary materials for clinical trials and the potential commercial launch of BRT-DA01, a treatment developed by BlueRock Therapeutics.
Leading Companies in the Cell Therapy Raw Materials Market
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher
- Sartorius Stedim Biotech
- Actylis
- ACROBiosystems
- STEMCELL Technologies
- Grifols, S.A.
- Charles River Laboratories
- RoosterBio, Inc.
- PromoCell GmbH
Recent Announcements by Industry Leaders
In September 2024, Dana Cipriano, Vice President of Analytical Services at SK Pharmteco, highlighted the importance of maintaining a secure and reliable supply chain in the rapidly growing cell and gene therapy sectors. Cipriano emphasized their partnership with Cryoport, which underscores their commitment to providing high-quality services tailored to meet both client and patient needs.
Key Developments in the Cell Therapy Raw Materials Market
In November 2024, QPS Holdings, LLC opened a new Cell Therapy business unit at their Springfield site in Missouri. This new facility includes a Leukopak collection and blood product processing center, designed to address the rising demand for blood products in cell and gene therapy.
In March 2024, ACROBiosystems launched a new initiative to support the development of advanced cell and gene therapies and ex vivo cell production. This new venture aims to assist manufacturers with cutting-edge solutions for cell-based treatments.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/cell-therapy-raw-materials-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5399
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
